retatrutide clinical trial malaysia A study of Lilly's weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk 🚨The first phase 3 retatrutide

However, there are some people speculating that cardio outcomes may be better if we're using oral estrogen

The PlexusDx intake process asks you to choose a GLP-1 preference before submission

When facial fat and muscle shrink quickly, the skin may look loose, deflated, or drawn instead of smooth and lifted

GLP-1s handle the timing

Retatrutide is a triple agonist (GIP, GLP-1, and glucagon receptors) while Ozempic activates only GLP-1 receptors, resulting in significantly greater weight loss, 24.2% versus 14.9% at standard doses

This personalized approach is crucial, as it ensures that patients can reap the full benefits of retatrutide while maintaining their quality of life throughout treatment